Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
methotrexate
methotrexate
- Formulary Anti-Neoplastic Formulary
- Restricted
VIEW MORE Antineoplastic Agents
High Alert Drug
: Policy
Last updated: Mar. 5, 2025
- Black Box Warning: Bone marrow, liver, lung and kidney toxicity risk
- HAZ-MED: Table 1
- Formulary, Not Routinely Stocked: Xatmep -> 2.5 mg/mL
ISMP oral methotrexate patient education leaflet
Methotrexate is a HIGH-RISK/HIGH-ALERT drug when used orally for non-oncology patients. Use extra caution when methrotrexate prescribed in non-oncology situations.
Xatmep is restricted to patients that are unable to take the oral tablet formulation.
High dose methotrexate drug interaction
High dose methotrexate process for Oncology pharmacists: Oncology pharmacist MTX process
High dose methotrexate process for evening/night shift pharmacists: SBAR for evening and night shift pharmacists
Reviewed: 24 Oct 2017 (Xatmep)
Updated: March 2023 (Xatmep)
HAZ-MED Liquid Preparations